Wave Life Sciences (WVE) Assets Average (2016 - 2026)
Wave Life Sciences (WVE) has disclosed Assets Average for 12 consecutive years, with $611.0 million as the latest value for Q1 2026.
- For Q1 2026, Assets Average rose 90.78% year-over-year to $611.0 million; the TTM value through Mar 2026 reached $611.0 million, up 90.78%, while the annual FY2025 figure was $495.4 million, 57.97% up from the prior year.
- Assets Average hit $611.0 million in Q1 2026 for Wave Life Sciences, up from $439.9 million in the prior quarter.
- Across five years, Assets Average topped out at $611.0 million in Q1 2026 and bottomed at $163.9 million in Q4 2022.
- Average Assets Average over 5 years is $273.6 million, with a median of $246.9 million recorded in 2025.
- Year-over-year, Assets Average dropped 28.27% in 2022 and then surged 90.78% in 2026.
- Wave Life Sciences' Assets Average stood at $163.9 million in 2022, then skyrocketed by 44.82% to $237.4 million in 2023, then soared by 49.67% to $355.4 million in 2024, then grew by 23.8% to $439.9 million in 2025, then surged by 38.89% to $611.0 million in 2026.
- According to Business Quant data, Assets Average over the past three periods came in at $611.0 million, $439.9 million, and $246.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.